Vijay Kumar
Stock Analyst at Evercore ISI Group
(2.27)
# 2,555
Out of 4,840 analysts
204
Total ratings
42.37%
Success rate
-4.45%
Average return
Main Sectors:
Stocks Rated by Vijay Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSUR OraSure Technologies | Maintains: In-Line | $3 | $2.78 | +8.11% | 4 | May 19, 2025 | |
| SYK Stryker | Maintains: Outperform | $400 → $390 | $383.78 | +1.62% | 10 | May 2, 2025 | |
| HOLX Hologic | Maintains: In-Line | $65 → $62 | $62.17 | -0.27% | 14 | May 2, 2025 | |
| EXAS Exact Sciences | Maintains: Outperform | $60 → $66 | $56.56 | +16.69% | 4 | May 2, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Outperform | $96 → $85 | $71.01 | +19.70% | 4 | May 1, 2025 | |
| BLCO Bausch + Lomb | Maintains: Outperform | $19 → $16 | $11.80 | +31.36% | 8 | May 1, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $585 → $500 | $403.55 | +23.90% | 11 | Apr 24, 2025 | |
| BSX Boston Scientific | Maintains: Outperform | $110 → $112 | $106.17 | +5.49% | 6 | Apr 24, 2025 | |
| ISRG Intuitive Surgical | Maintains: In-Line | $510 → $470 | $550.19 | -14.57% | 12 | Apr 23, 2025 | |
| EW Edwards Lifesciences | Maintains: In-Line | $75 → $73 | $76.22 | -4.22% | 11 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $1,450 → $1,475 | $1,162.84 | +26.84% | 9 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $50 → $52 | $27.72 | +87.59% | 6 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $207 → $202 | $140.00 | +44.29% | 6 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $18 → $30 | $19.18 | +56.41% | 11 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $145 → $142 | $111.26 | +27.63% | 3 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $51 → $54 | $43.74 | +23.46% | 4 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $113 → $110 | $94.21 | +16.76% | 12 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $335 → $355 | $358.36 | -0.94% | 8 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $52 → $56 | $29.41 | +90.41% | 5 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $160 | $113.48 | +40.99% | 7 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $104 | $81.18 | +28.11% | 4 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $62 → $58 | $33.44 | +73.44% | 3 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $278 | $189.18 | +46.95% | 2 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $286 → $290 | $174.51 | +66.18% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $124 | $132.94 | -6.72% | 10 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $45 | $30.87 | +45.77% | 6 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $27 | $13.15 | +105.32% | 10 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $195 → $175 | $82.49 | +112.15% | 6 | Jun 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $88 → $125 | $92.23 | +35.53% | 1 | Jan 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $0.66 | +960.61% | 1 | May 31, 2022 |
OraSure Technologies
May 19, 2025
Maintains: In-Line
Price Target: $3
Current: $2.78
Upside: +8.11%
Stryker
May 2, 2025
Maintains: Outperform
Price Target: $400 → $390
Current: $383.78
Upside: +1.62%
Hologic
May 2, 2025
Maintains: In-Line
Price Target: $65 → $62
Current: $62.17
Upside: -0.27%
Exact Sciences
May 2, 2025
Maintains: Outperform
Price Target: $60 → $66
Current: $56.56
Upside: +16.69%
GE HealthCare Technologies
May 1, 2025
Maintains: Outperform
Price Target: $96 → $85
Current: $71.01
Upside: +19.70%
Bausch + Lomb
May 1, 2025
Maintains: Outperform
Price Target: $19 → $16
Current: $11.80
Upside: +31.36%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $585 → $500
Current: $403.55
Upside: +23.90%
Boston Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $110 → $112
Current: $106.17
Upside: +5.49%
Intuitive Surgical
Apr 23, 2025
Maintains: In-Line
Price Target: $510 → $470
Current: $550.19
Upside: -14.57%
Edwards Lifesciences
Feb 12, 2025
Maintains: In-Line
Price Target: $75 → $73
Current: $76.22
Upside: -4.22%
Feb 10, 2025
Maintains: Outperform
Price Target: $1,450 → $1,475
Current: $1,162.84
Upside: +26.84%
Feb 6, 2025
Maintains: In-Line
Price Target: $50 → $52
Current: $27.72
Upside: +87.59%
Jan 17, 2025
Maintains: Outperform
Price Target: $207 → $202
Current: $140.00
Upside: +44.29%
Dec 2, 2024
Upgrades: Outperform
Price Target: $18 → $30
Current: $19.18
Upside: +56.41%
Nov 26, 2024
Maintains: In-Line
Price Target: $145 → $142
Current: $111.26
Upside: +27.63%
Oct 30, 2024
Maintains: In-Line
Price Target: $51 → $54
Current: $43.74
Upside: +23.46%
Oct 1, 2024
Maintains: In-Line
Price Target: $113 → $110
Current: $94.21
Upside: +16.76%
Oct 1, 2024
Maintains: In-Line
Price Target: $335 → $355
Current: $358.36
Upside: -0.94%
Oct 1, 2024
Maintains: Outperform
Price Target: $52 → $56
Current: $29.41
Upside: +90.41%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $160
Current: $113.48
Upside: +40.99%
Oct 1, 2024
Maintains: Outperform
Price Target: $100 → $104
Current: $81.18
Upside: +28.11%
Oct 1, 2024
Maintains: Outperform
Price Target: $62 → $58
Current: $33.44
Upside: +73.44%
Oct 1, 2024
Maintains: Outperform
Price Target: $275 → $278
Current: $189.18
Upside: +46.95%
Oct 1, 2024
Maintains: Outperform
Price Target: $286 → $290
Current: $174.51
Upside: +66.18%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $124
Current: $132.94
Upside: -6.72%
Jul 2, 2024
Maintains: Outperform
Price Target: $46 → $45
Current: $30.87
Upside: +45.77%
Jul 2, 2024
Maintains: Outperform
Price Target: $28 → $27
Current: $13.15
Upside: +105.32%
Jun 11, 2024
Maintains: Outperform
Price Target: $195 → $175
Current: $82.49
Upside: +112.15%
Jan 4, 2024
Upgrades: Outperform
Price Target: $88 → $125
Current: $92.23
Upside: +35.53%
May 31, 2022
Initiates: Outperform
Price Target: $7
Current: $0.66
Upside: +960.61%